Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1963
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 1
1968 2
1969 2
1972 1
1973 1
1974 4
1975 1
1976 2
1979 1
1982 1
1983 1
1985 2
1986 7
1987 1
1989 1
1990 1
1991 4
1992 5
1993 5
1994 4
1995 10
1996 5
1997 11
1998 8
1999 7
2000 7
2001 12
2002 10
2003 12
2004 4
2005 7
2006 6
2007 5
2008 7
2009 8
2010 4
2011 3
2012 14
2013 18
2014 6
2015 15
2016 19
2017 18
2018 17
2019 14
2020 20
2021 16
2022 9
2023 12
2024 20
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

347 results

Results by year

Filters applied: . Clear all
Page 1
Genetic Epilepsy Syndromes.
Myers KA. Myers KA. Continuum (Minneap Minn). 2022 Apr 1;28(2):339-362. doi: 10.1212/CON.0000000000001077. Continuum (Minneap Minn). 2022. PMID: 35393962 Review.
Genetic generalized epilepsy, self-limited focal epilepsy of childhood, self-limited neonatal and infantile epilepsy, select developmental and epileptic encephalopathies, progressive myoclonus epilepsies, sleep-related hypermotor epilepsy, photosensitive occipital lobe epi …
Genetic generalized epilepsy, self-limited focal epilepsy of childhood, self-limited neonatal and infantile epilepsy, select developmental a …
Epilepsy With Eyelid Myoclonia (Jeavons Syndrome).
Zawar I, Knight EP. Zawar I, et al. Pediatr Neurol. 2021 Aug;121:75-80. doi: 10.1016/j.pediatrneurol.2020.11.018. Epub 2020 Dec 1. Pediatr Neurol. 2021. PMID: 34167046 Review.
The purpose of this review is to provide a comprehensive update and highlight the distinct electroclinical features and discuss recent advances in the etiology, pathophysiology, and management strategies of epilepsy with eyelid myoclonia. Recent studies indicate tha …
The purpose of this review is to provide a comprehensive update and highlight the distinct electroclinical features and discuss recent advan …
Unverricht-Lundborg disease.
Crespel A, Ferlazzo E, Franceschetti S, Genton P, Gouider R, Kälviäinen R, Korja M, Lehtinen MK, Mervaala E, Simonato M, Vaarmann A. Crespel A, et al. Epileptic Disord. 2016 Sep 1;18(S2):28-37. doi: 10.1684/epd.2016.0841. Epileptic Disord. 2016. PMID: 27582036 Review.
We first review the clinical presentation and current therapeutic approaches available for treating Unverricht-Lundborg disease (ULD), a progressive myoclonus epilepsy. Next, we describe the identification of disease causing mutations in the gene encoding cystatin B (CSTB) …
We first review the clinical presentation and current therapeutic approaches available for treating Unverricht-Lundborg disease (ULD), a pro …
Antibiotic-associated encephalopathy.
Bhattacharyya S, Darby RR, Raibagkar P, Gonzalez Castro LN, Berkowitz AL. Bhattacharyya S, et al. Neurology. 2016 Mar 8;86(10):963-71. doi: 10.1212/WNL.0000000000002455. Epub 2016 Feb 17. Neurology. 2016. PMID: 26888997 Review.
AAE can be divided into 3 unique clinical phenotypes: encephalopathy commonly accompanied by seizures or myoclonus arising within days after antibiotic administration (caused by cephalosporins and penicillin); encephalopathy characterized by psychosis arising within …
AAE can be divided into 3 unique clinical phenotypes: encephalopathy commonly accompanied by seizures or myoclonus arising wit …
Cefepime-induced neurotoxicity: a systematic review.
Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, Fraser GL. Payne LE, et al. Crit Care. 2017 Nov 14;21(1):276. doi: 10.1186/s13054-017-1856-1. Crit Care. 2017. PMID: 29137682 Free PMC article. Review.
Neurotoxic symptoms include depressed consciousness, encephalopathy, aphasia, myoclonus, seizures, and coma. Data suggest that up to 15% of ICU patients treated with cefepime may experience these adverse effects. ...Search terms included cefepime, neurotoxicity, enc …
Neurotoxic symptoms include depressed consciousness, encephalopathy, aphasia, myoclonus, seizures, and coma. Data suggest that …
Progressive Myoclonus Epilepsy: A Scoping Review of Diagnostic, Phenotypic and Therapeutic Advances.
Zimmern V, Minassian B. Zimmern V, et al. Genes (Basel). 2024 Jan 27;15(2):171. doi: 10.3390/genes15020171. Genes (Basel). 2024. PMID: 38397161 Free PMC article. Review.
The progressive myoclonus epilepsies (PME) are a diverse group of disorders that feature both myoclonus and seizures that worsen gradually over a variable timeframe. While each of the disorders is individually rare, they collectively make up a non-trivial por …
The progressive myoclonus epilepsies (PME) are a diverse group of disorders that feature both myoclonus and seizures th …
Sepsis-associated encephalopathy.
Gofton TE, Young GB. Gofton TE, et al. Nat Rev Neurol. 2012 Oct;8(10):557-66. doi: 10.1038/nrneurol.2012.183. Epub 2012 Sep 18. Nat Rev Neurol. 2012. PMID: 22986430 Review.
The severity of SAE can range from mild delirium to deep coma. Seizures and myoclonus are infrequent and cranial nerves are almost always spared, but most severe cases have an associated critical illness neuromyopathy. ...
The severity of SAE can range from mild delirium to deep coma. Seizures and myoclonus are infrequent and cranial nerves are al …
Parkinson's disease - genetic cause.
Cherian A, K P D, Vijayaraghavan A. Cherian A, et al. Curr Opin Neurol. 2023 Aug 1;36(4):292-301. doi: 10.1097/WCO.0000000000001167. Epub 2023 May 24. Curr Opin Neurol. 2023. PMID: 37366140 Review.
X-linked parkinsonism manifests at a young age accompanied by many (atypical) features such as intellectual disability, spasticity, seizures, myoclonus, dystonia, and have poor response to levodopa. SUMMARY: This review article aims to provide a comprehensive overvi …
X-linked parkinsonism manifests at a young age accompanied by many (atypical) features such as intellectual disability, spasticity, seizu
Epilepsy.
Friedlander WJ. Friedlander WJ. Prog Neurol Psychiatry. 1968;23:203-41. Prog Neurol Psychiatry. 1968. PMID: 4388825 Review. No abstract available.
Update on the management of status epilepticus.
Rossetti AO, Alvarez V. Rossetti AO, et al. Curr Opin Neurol. 2021 Apr 1;34(2):172-181. doi: 10.1097/WCO.0000000000000899. Curr Opin Neurol. 2021. PMID: 33664203 Review.
The recently published ESETT trial provides high-level evidence regarding the equivalence of fosphenytoin, valproate, and levetiracetam as a second-line option. Myoclonus or epileptiform transients on electroencephalography occur in up to 1/3 of patients surviving a cardia …
The recently published ESETT trial provides high-level evidence regarding the equivalence of fosphenytoin, valproate, and levetiracetam as a …
347 results